Chison Medical Technologies Co.Ltd(688358) 4 on April 18, the annual report of 2021 was released. In 2021, the company achieved an operating revenue of 398 million yuan, with a year-on-year increase of 19.43%; The net profit attributable to the parent company was 112 million yuan, with a year-on-year increase of 12.88%, of which the year-on-year increase of overseas income was more significant. On the same day, the company also disclosed the first quarterly report of 2022, realizing an operating revenue of 100 million yuan, a year-on-year increase of 23.04%; The net profit attributable to the parent company was 25 million yuan, a year-on-year increase of 9.05%.
This report card is basically in line with expectations, especially in terms of overseas income. Benefiting from the new medical infrastructure and the recovery of global demand for ultrasonic equipment, as well as the company's own advantages in technology research and development and product promotion, the company's overseas income still has great growth potential in the future.
According to public information, Chison Medical Technologies Co.Ltd(688358) since opening up overseas markets in 2002, it has 20 years of experience and strong ability to deal with market fluctuation risks. At present, the company's marketing channels are mainly export-oriented, and its products are exported to more than 100 countries and regions.
According to the announcement, the overseas revenue in 2021 was 345 million yuan, accounting for 87.38%. According to the data, Chison Medical Technologies Co.Ltd(688358) is one of the few companies whose overseas business in the field of medical device specialty accounts for 80%.
In 2021, Chison Medical Technologies Co.Ltd(688358) increased investment in sales expenses and vigorously explored foreign markets. Carry out local marketing network layout in India, Mexico, Italy, Brazil and other markets, and further promote the smooth implementation of overseas brand construction and marketing achievements. With a capable and efficient marketing team and accurate marketing strategy, the company's penetration in overseas markets has been continuously improved. Especially in the American market, the company's product sales have increased significantly and can provide customers with high value-added products.
At the same time, judging from the sales situation of Chison Medical Technologies Co.Ltd(688358) overseas sub regions, there is a certain degree of differentiation. Germany, Italy, Spain and other European markets, while the overall sales revenue has increased steadily, have realized the coverage of products across medical institutions. The company's products have successfully entered the local pension system and rehabilitation physiotherapy market. In emerging markets represented by India, the Philippines, Indonesia, Mexico, Argentina and other countries, the product sales have nearly doubled, and the acceptance of high-end products has also exceeded expectations.
It is worth mentioning that the company started the construction of a global intelligent innovation R & D center with a construction area of about 27000 square meters in the second half of 2021 and is expected to be put into use in the first half of 2023, which will provide a solid backing for the company's development in overseas markets in the future.
In terms of supply chain, due to the repeated international epidemic and other factors, there is a shortage of materials for electronic components such as international chips, and there is great uncertainty in the delivery date. In order to ensure the supply chain and the timely delivery rate to customers, the company has taken the initiative to conduct strategic procurement and reserve of core materials to meet the order demand, which fully demonstrates the company's confidence in continuing to explore the overseas market.
At the same time, based on the company's professionalism and long-term cooperation with suppliers, suppliers have strong stickiness. Chison Medical Technologies Co.Ltd(688358) at present, the supply link is stable and sufficient, which can effectively ensure the production capacity required by the overseas market.
In terms of charitable donations, Chison Medical Technologies Co.Ltd(688358) has successively donated equipment to several charities; In case of sudden flood in Henan, the company launched emergency rescue and donated portable notebook ultrasound and palm ultrasound for flood first aid; The company actively responded to the work of aid to Xinjiang and Tibet and donated epidemic prevention materials and color Doppler ultrasound equipment for medical assistance. In addition, Chison Medical Technologies Co.Ltd(688358) will also configure 5g + sonoeye handheld ultrasound to the medical security group of 2022 Winter Olympic Games to guard Olympic athletes of all countries throughout the process; During the covid-19 epidemic, the company actively applied 5g + sonoeye palm ultrasound to the prevention, treatment and treatment of covid-19 to contribute to the anti epidemic action.
In the future, Chison Medical Technologies Co.Ltd(688358) will further promote 5g + sonoeye to further serve the new model and scene of medical services. According to the data of signifyresearch, the global market scale of ultrasonic medical imaging equipment in 2019 was 230614 sets / set, which is expected to grow to 349589 sets / set in 2023, with a compound annual growth rate of 10.96%. With the gradual acceleration of global aging, medical expenditure will continue to grow, and the global ultrasound market will usher in new opportunities. As a national medical device brand, Chison Medical Technologies Co.Ltd(688358) will actively comply with the development trend of the industry, continue to increase investment in the development of overseas markets, promote more and deeper localization strategies, and continue to give full play to its advantages in technology research and development to advance to the global leading ultrasonic enterprises.
